Fortune recently reported that the U.S. could need as many as 40 new nuclear plants over the next five years to power all data centers, crypto miners, and cannabis facilities that require electricity. That should be a boon for nuclear energy stocks.“After being flat for nearly two decades, demand for power in the U.S. is soaring. A recent report by Grid Strategies, a power sector consulting company, estimated that yearly electricity demand is set to grow by 0.9%, while the capacity added to the grid is plan ...

The challenging macroeconomic environment and end-market volatility worldwide have affected the Zacks Electronics - Miscellaneous Components industry. Moreover, geo-political tensions, unfavorable forex and rising recessionary fears weigh on the industry’s prospects.Nevertheless, TE Connectivity (TEL) , BWX Technologies (BWXT) and Novanta (NOVT) are well-poised to benefit from the solid adoption of AI and the democratization of IoT techniques, which are transforming robotics, transportation systems, retail ...

LYNCHBURG, Va.--(BUSINESS WIRE)--BWX Technologies, Inc. (NYSE: BWXT) has released its 2024 Sustainability Report, demonstrating the company’s role in good governance, environmental stewardship, the ongoing global clean-energy transition, global security, investment in the communities where we operate, and many other initiatives critical to corporate social responsibility (CSR) excellence. “At BWXT, we are committed to the employment of nuclear technology to solve some of the world’s most important proble ...

BWX Technologies (BWXT) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.The po ...

Investors interested in Computer and Technology stocks should always be looking to find the best-performing companies in the group. Is BWX Technologies (BWXT) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out.BWX Technologies is one of 622 companies in the Computer and Technology group. The Computer and Technology group currently sits at #5 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Ran ...

LYNCHBURG, Va.--(BUSINESS WIRE)--BWX Technologies, Inc. (NYSE: BWXT) today announced a contract with an estimated value of up to $45 billion over a 10-year ordering period from the U.S. Department of Energy (DOE) for environmental management operations at the Hanford Site in Washington. The DOE announced that the Hanford Integrated Tank Disposition Contract (ITDC) was awarded to Hanford Tank Waste Operations & Closure, LLC (H2C), which is a joint venture led by a BWXT subsidiary and includes subsidiaries ...

LYNCHBURG, Va.--(BUSINESS WIRE)--BWX Technologies, Inc. (NYSE: BWXT) is hosting an Investor Day with financial analysts and institutional investors today, February 28, 2024, at 8:30 a.m. to approximately 11:30 a.m. ET. During the event, BWXT management will discuss its business, strategic direction and growth outlook. There will also be a live question and answer session following the prepared remarks. Among the presenters will be: Rex Geveden, President and Chief Executive Officer Robb LeMasters, Seni ...

Financial Data and Key Metrics Changes - The company reported 2023 revenue of $2.5 billion, a 12% increase compared to the previous year, with adjusted EBITDA up 7% for the year [3][9] - Fourth quarter adjusted earnings per share (EPS) was $1.01, an 8% increase from $0.93 last year, while full year adjusted EPS was $3.02, down from $3.13 in 2022 [9][100] - Free cash flow for the year was $212 million, significantly up from 2022, driven by strong working capital management [28][106] Business Line Data and Key Metrics Changes - Government Operations revenue in Q4 was up 16% to $602 million, with adjusted EBITDA of $131 million, a 13% increase from last year [10] - Commercial Operations revenue also grew by 16%, driven by nearly 40% growth in medical, with adjusted EBITDA increasing to $21.3 million from $13.6 million last year [29][100] - The medical segment achieved a positive EBITDA position, marking a significant turnaround [8][25] Market Data and Key Metrics Changes - The company continues to see strong demand in the small modular reactor (SMR) market and is well-positioned as a merchant supplier [6] - The global nuclear energy market is gaining momentum, with over 20 countries committing to tripling nuclear energy by 2050 [102] - The company is experiencing healthy demand for diagnostic isotopes and expects similar growth in 2024, complemented by increasing sales of therapeutic isotopes [25][102] Company Strategy and Development Direction - The company is focused on operational excellence initiatives, including improvements in operational equipment effectiveness and supply chain management [5] - There is a commitment to driving predictable earnings and free cash flow conversion with a balanced capital allocation approach [12] - The company signed a net zero nuclear industry pledge, indicating a long-term commitment to nuclear energy [24] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in continued growth in 2024, driven by strong demand trends across global security, clean energy, and medical end markets [12][124] - The company expects mid-single-digit revenue growth in 2024, with government operations growth in the low to mid-single digits [128] - Management highlighted the importance of talent acquisition and management as foundational components of the operating strategy [120] Other Important Information - The company was awarded a $300 million contract for naval nuclear fuel manufacturing through mid-2025 [4] - Capital expenditures for the full year were $150 million, consistent with maintenance requirements and select growth investments [127] Q&A Session Summary Question: What isotopes are driving growth in BWX Medical? - Management noted strong growth across the portfolio, particularly in actinium and lutetium, with no forecast for tech-99 in 2024 [15][25] Question: How is the Hanford Tank project treated in guidance? - Management indicated that the Hanford project is included in guidance but is not expected to have a meaningful impact [16][113] Question: What is the current status of the tech-99 FDA approval process? - Management confirmed that there are no changes in the approval timeline and still expects commercialization in 2024 [69][70] Question: What is driving the momentum in government operations? - Management highlighted the ramp-up of the DRACO space microreactor program and growth in non-naval projects as key drivers [79][81] Question: Are there any risks related to the budget environment? - Management stated that while some government programs could be affected by continuing resolutions, the overall business is well insulated from such risks [82][96]

BWX Technologies (BWXT) came out with quarterly earnings of $1.01 per share, beating the Zacks Consensus Estimate of $0.94 per share. This compares to earnings of $0.93 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 7.45%. A quarter ago, it was expected that this supplier of nuclear fuel and components to the U.S. government would post earnings of $0.66 per share when it actually produced earnings of $0.67, delivering a surpr ...

Our Mission: We provide safe and effective Fourth Quarter 2023 and Outlook Highlights on ensuring the highest ESG standards medicine, and space exploration ‒ Secured key special materials wins: U-Metal conversion and purification; HALEU feedstock; Downblending extension through 2027 4 Our Purpose: We employ nuclear technology to solve some of the world's most important problems Fourth-Quarter 2023 Earnings medicine, and space exploration Commitment to innovation, operational Forward-Looking Statements Discl ...